Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
Trodelvy Market Size Outlook: How Quickly Will Revenue Expand Through 2030?
The growth witnessed during the historical period stemmed from an escalating incidence of metastatic breast cancer, coupled with progress in monoclonal antibody engineering, the expansion of oncology clinical trials, a broadening adoption of targeted cancer therapies, and more efficient regulatory pathways for oncology drugs.
Growth in the forecast period is anticipated due to the broadening of personalized cancer treatment protocols, increasing investments in the development of antibody-drug conjugate pipelines, wider adoption of biomarker-driven therapies, advancements in linker and payload technologies, and a growing demand for improved cancer survival outcomes. Significant trends during the forecast period encompass the increasing acceptance of antibody-drug conjugate therapies, a rising emphasis on targeted oncology treatments, the expansion of Trop-2 targeted therapeutics, a growing application of precision oncology approaches, and enhanced drug delivery mechanisms.
Get A Free Sample Report With In-Depth Market Insights:
Trodelvy Market Growth Factors: What’s Supporting Expansion?
A growing occurrence of breast cancer is anticipated to fuel the expansion of the trodelvy market in the future. Breast cancer is characterized by the development of malignant cells within breast tissues, ranking among the most prevalent cancers globally, impacting both women and, less frequently, men. This rise in breast cancer cases stems from factors such as genetic susceptibility, shifts in lifestyle, and heightened awareness, prompting increased global spending on innovative treatments and healthcare infrastructure. Trodelvy offers benefits to breast cancer patients through its effective targeted therapy for advanced or metastatic forms, contributing to better survival rates and addressing the rising healthcare demands linked to the high prevalence of breast cancer. For example, data from the American Cancer Society, a US-based non-profit cancer advocacy organization, indicates that approximately 313,510 new breast cancer cases were diagnosed in 2024, showing an increase from the 300,590 cases reported in 2023. Consequently, the elevated incidence of breast cancer is a significant driver for the growth of the trodelvy market.
Trodelvy Market Segment Outlook: Which Categories Are Growing Fastest?
The trodelvy market covered in this report is segmented –
1) By Indication: Metastatic Triple-Negative Breast Cancer (mTNBC), HR+ Or HER2-Negative Breast Cancer, Metastatic Urothelial Cancer
2) By Distribution Channel: Hospitals And Clinics, Retail And Specialty Pharmacies
3) By End User: Adult Patients, Geriatric Patients
Trodelvy Market Industry Trends: What’s Reshaping Demand?
Companies active in the trodelvy market are broadening treatment indications to offer a wider array of patients advanced, targeted therapies that improve survival outcomes and quality of life. This strategy addresses various unmet medical needs in multiple oncology indications, thereby enhancing the drug’s clinical impact and commercial potential across diverse patient populations. For instance, in February 2023, Gilead Sciences Inc., a US-based pharmaceutics company, obtained expanded United States approval for Trodelvy to treat HR-positive and HER2-negative metastatic breast cancer, significantly expanding the market and reaching a larger patient demographic. This constitutes a strategic advancement for trodelvy, enabling it to compete more effectively in the broader breast cancer treatment landscape.
Trodelvy Market Leading Companies And Competitive Benchmarking
Major companies operating in the trodelvy market are Gilead Sciences Inc.
View The Full Trodelvy Market Report:
Trodelvy Market Top Region By Revenue And Market Share
North America was the largest region in the trodelvy market in 2025. The regions covered in the trodelvy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
